As a part of our mission to develop innovative oncology and hematology therapeutics for patients with cancer, Stemline acknowledges the important role of partnering with the community to support ongoing medical education. Stemline expects that all requests have a compelling rationale, supported by available data, with the potential to enhance the understanding of our medicines, deliver innovative therapies to patients, address unmet medical needs, and improve patient care. All proposed activities will align with our priorities and maintain the privacy rights, safety, and the welfare of patients. To submit a proposal, visit our submission portal for further instructions.

As a part of our mission to develop innovative therapeutics for patients with unmet need, Menarini Stemline acknowledges the important role of partnering with the medical and scientific community to conduct ethical and impactful independent and collaborative medical research. We can support Independent and Collaborative Research through the provision of drug(s), funding, supplies, and/or in-kind services.

Independent Scientific Research: Research that is initiated, planned, and conducted by an independent external researcher or sponsor. Menarini Stemline does not take any regulatory or legal responsibility for the study or assist with research activities. Known throughout our industry as Investigator Sponsored Research, Investigator Initiated Trials, Investigator Sponsored Studies, etc.

Collaborative Scientific Research: Research that is initiated, planned and conducted by an external researcher or sponsor. Menarini Stemline may assist with one or more research activities, which will be dependent on the project.

Menarini Stemline expects that all requests contain a compelling rationale, supported by available data, with the potential to enhance the understanding of our medicines, deliver innovative therapies to patients, address unmet medical needs, and improve patient care. We employ a careful, cross functional evaluation of the scientific merit and strategic relevance of each request we receive. When proposed research is expected to take place in humans, the privacy rights, safety, and the welfare of patients are paramount

Our program accepts requests for the following types of Medical Research:

• Non-Interventional Research (i.e., Real World Evidence, Observational, and/or Health Outcomes and Economics Research): Research utilizing data collected in either a prospective or retrospective manner, of the observation of clinical practices and/or patient reported experiences

As a part of our mission to develop innovative therapeutics for patients with unmet need, Menarini Stemline acknowledges the important role of partnering with the medical and scientific community to conduct ethical and impactful independent and collaborative medical research. We can support Independent and Collaborative Research through the provision of drug(s), funding, supplies, and/or in-kind services.

Independent Scientific Research: Research that is initiated, planned, and conducted by an independent external researcher or sponsor. Menarini Stemline does not take any regulatory or legal responsibility for the study or assist with research activities. Known throughout our industry as Investigator Sponsored Research, Investigator Initiated Trials, Investigator Sponsored Studies, etc.

Collaborative Scientific Research: Research that is initiated, planned and conducted by an external researcher or sponsor. Menarini Stemline may assist with one or more research activities, which will be dependent on the project.

Menarini Stemline expects that all requests contain a compelling rationale, supported by available data, with the potential to enhance the understanding of our medicines, deliver innovative therapies to patients, address unmet medical needs, and improve patient care. We employ a careful, cross functional evaluation of the scientific merit and strategic relevance of each request we receive. When proposed research is expected to take place in humans, the privacy rights, safety, and the welfare of patients are paramount.

Our program accepts requests for the following types of Medical Research:

• Interventional Research (Phases I-IV): Clinical research involving one or more of Menarini Stemline’s products

As a part of our mission to develop innovative oncology and hematology therapeutics for patients with cancer, Stemline acknowledges the important role of partnering with the community to support patient advocacy activities. Stemline expects that all requests have a compelling rationale, supported by available data, with the potential to enhance the understanding of our medicines, deliver innovative therapies to patients, address unmet medical needs, and improve patient care. All proposed activities will align with our priorities and maintain the privacy rights, safety, and the welfare of patients. To submit a proposal, visit our submission portal for further instructions.

As a part of our mission to develop innovative oncology and hematology therapeutics for patients with cancer, Stemline acknowledges the important role of partnering with the community to support ongoing medical education. Stemline expects that all requests have a compelling rationale, supported by available data, with potential to enhance the understanding of our medicines, deliver innovative therapies to patients, address unmet medical needs, and improve patient care. All proposed activities will align with our priorities and maintain the privacy rights, safety, and the welfare of patients.

Our program accepts requests for the following types of proposals. Please submit proposals to grants@menarinistemline.com. The team will review and respond to proposals in a timely manner.

• Medical Education Grants

As a part of our mission to develop innovative oncology and hematology therapeutics for patients with cancer, Stemline acknowledges the important role of partnering with the community to support third party sponsorships, patient advocacy activities and charitable donations. Stemline expects that all requests have a compelling rationale, supported by available data, with potential to enhance the understanding of our medicines, deliver innovative therapies to patients, address unmet medical needs, and improve patient care. All proposed activities will align with our priorities and maintain the privacy rights, safety, and the welfare of patients.

Our program accepts requests for the following types of proposals. Please submit proposals to grants@menarinistemline.com.The team will review and respond to proposals in a timely manner.

• Third Party Sponsorships & Events
• Patient Advocacy Support
• Charitable Grants & Donations

As a part of our mission to develop innovative oncology therapeutics for patients with cancer, Stemline acknowledges the important role of partnering with the scientific community to conduct ethical independent and collaborative research. Stemline considers external requests for study drug, a financial contribution, and/or other requested support for the conduct of such studies. Stemline’s global and regional cross functional teams evaluate the scientific merit and strategic relevance of each submission carefully.

Stemline expects that all requests have a compelling rationale, supported by available data, with potential to enhance the understanding of our medicines, deliver innovative therapies to patients, address unmet medical needs, and improve patient care. When proposed research is expected to take place in humans, the privacy rights, safety, and the welfare of patients is paramount.

Our program accepts requests for the following study types:

• Interventional Clinical Research (Phases I-IV): Clinical research involving one or more of Stemline’s products
• Observational Research (i.e. Real-World Evidence or Health Outcomes and Economics Research): Research utilizing data collected in either a prospective or retrospective manner, of the observation of clinical practices and/or patient reported experiences